Employee’s Preferences for Access to Mindfulness-Based Cognitive Therapy to Reduce the Risk of Depressive Relapse—A Discrete Choice Experiment

[1]  M. Cho,et al.  Economic burden of depression in South Korea , 2012, Social Psychiatry and Psychiatric Epidemiology.

[2]  Scot Simpson,et al.  A discrete choice experiment evaluation of patients’ preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management , 2010, Patient preference and adherence.

[3]  Z. Segal,et al.  Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. , 2010, Archives of general psychiatry.

[4]  David Patrick,et al.  Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme , 2010, Sexually Transmitted Infections.

[5]  Sona Dimidjian,et al.  Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. , 2010, Behaviour research and therapy.

[6]  L. Lynd,et al.  A valuation of patients' willingness-to-pay for insulin delivery in diabetes , 2009, International Journal of Technology Assessment in Health Care.

[7]  J. Callahan,et al.  The impact of client treatment preferences on outcome: a meta-analysis. , 2009, Journal of clinical psychology.

[8]  Willem Kuyken,et al.  Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. , 2008, Journal of consulting and clinical psychology.

[9]  Arne Risa Hole,et al.  Modelling heterogeneity in patients' preferences for the attributes of a general practitioner appointment. , 2008, Journal of health economics.

[10]  L. Lynd,et al.  An Evaluation of Patients' Willingness to Trade Symptom-Free Days for Asthma-Related Treatment Risks: A Discrete Choice Experiment , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[11]  E. Ernst,et al.  Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. , 2007, Journal of consulting and clinical psychology.

[12]  D. Bhugra,et al.  Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey , 2007, Acta psychiatrica Scandinavica.

[13]  R. Kessler,et al.  Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. , 2006, The American journal of psychiatry.

[14]  Emily Lancsar,et al.  Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences? , 2006, Health economics.

[15]  J. Angst,et al.  Cost of depression in Europe. , 2006, The journal of mental health policy and economics.

[16]  Jian Li Wang,et al.  Descriptive Epidemiology of Major Depression in Canada , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[17]  A. Lang.  Mental Health Treatment Preferences of Primary Care Patients , 2005, Journal of Behavioral Medicine.

[18]  A. Lesage,et al.  Nature and prevalence of mental illness in the workplace. , 2004, HealthcarePapers.

[19]  Ronald C Kessler,et al.  Effects of major depression on moment-in-time work performance. , 2004, The American journal of psychiatry.

[20]  Joffre Swait,et al.  Using stated preference and revealed preference modeling to evaluate prescribing decisions. , 2004, Health economics.

[21]  J. Teasdale,et al.  Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. , 2004, Journal of consulting and clinical psychology.

[22]  Ronald C Kessler,et al.  The economic burden of depression in the United States: how did it change between 1990 and 2000? , 2003, The Journal of clinical psychiatry.

[23]  Mandy Ryan,et al.  Using discrete choice experiments to value health care programmes: current practice and future research reflections. , 2003, Applied health economics and health policy.

[24]  T. Barnhofer.  Mindfulness-based cognitive therapy for depression: A new approach for preventing relapse , 2002 .

[25]  P. Zweifel,et al.  Measuring willingness-to-pay for risk reduction: an application of conjoint analysis. , 2002, Health economics.

[26]  M. Hagen,et al.  Ethical principles of psychologists and code of conduct. , 2002, The American psychologist.

[27]  D. McFadden,et al.  MIXED MNL MODELS FOR DISCRETE RESPONSE , 2000 .

[28]  Z. Segal,et al.  Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. , 2000, Journal of consulting and clinical psychology.

[29]  M. Ryan,et al.  Using discrete choice modelling in priority setting: an application to clinical service developments. , 2000, Social science & medicine.

[30]  D. Eisenberg,et al.  A combined algorithm for genome-wide prediction of protein function , 1999, Nature.

[31]  R. Bland,et al.  Incidence of mental disorders in Edmonton: estimates of rates and methodological issues. , 1998, Journal of psychiatric research.

[32]  L. Judd.  The clinical course of unipolar major depressive disorders. , 1997, Archives of general psychiatry.

[33]  D. Offord,et al.  One-Year Prevalence of Psychiatric Disorder in Ontarians 15 to 64 Years of Age , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[34]  P W Lavori,et al.  Predictors of relapse in major depressive disorder. , 1983, JAMA.

[35]  A. Perl,et al.  Code of Ethics , 1963, Science.